Want to see SE:HNSA full AI Analyst Report?
Hansa Biopharma AB (HNSA) Income Statement
Hansa Biopharma AB Income Statement
Last quarter (Q2 2026), Hansa Biopharma AB's total revenue was $48.10M, a decrease of 2.09% from the same quarter last year. In Q2, Hansa Biopharma AB's net income was $-260.54M. See Hansa Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 222.26M | $ 171.32M | $ 134.09M | $ 154.53M | $ 33.88M | |
| $ 138.71M | $ 87.76M | $ 70.95M | $ 116.05M | $ 18.45M | |
| $ 659.42M | $ 725.64M | $ 859.45M | $ 692.17M | $ 558.03M | |
| Depreciation and Amortization | $ 38.76M | $ 28.06M | $ 19.79M | $ 12.05M | $ 8.61M |
| $ -483.82M | $ -642.07M | $ -705.50M | $ -554.26M | $ -538.83M | |
| $ -520.71M | $ -637.88M | $ -788.50M | $ -576.12M | $ -539.58M | |
| $ -9.27M | $ -166.33M | $ -42.32M | $ -33.86M | $ -1.15M | |
| $ -531.84M | $ -804.21M | $ -830.81M | $ -609.98M | $ -548.13M | |
| $ -534.11M | $ -807.24M | $ -831.72M | $ -611.13M | $ -548.28M | |
| Per Share Metrics | |||||
| Basic EPS | $ -6.52 | $ -12.84 | $ -15.83 | $ -13.60 | $ -12.33 |
| Diluted EPS | $ -6.52 | $ -12.84 | $ -15.83 | $ -13.60 | $ -12.33 |
| Weighted Average Shares Outstanding | 81.20M | 62.83M | 52.54M | 44.92M | 44.47M |
| Weighted Average Shares Outstanding (Diluted) | 81.20M | 62.83M | 52.54M | 44.92M | 44.47M |
Currency in SEK